COVID-19大流行对儿童风湿病学实践的影响:一项国际横断面调查研究
该国际横断面调查由儿童风湿病欧洲学会(PReS)新兴风湿病学家与研究者(EMERGE)组代表通过SurveyMonkey创建含22个问题的在线问卷,收集70个国家469名儿童风湿病学家的回答。结果显示大流行改变了儿童风湿病学实践,包括处方抗风湿药物更谨慎、向远程医疗转变、常规诊疗延迟以及COVID-19相关炎症性疾病增加。
要点
- 65.3%的受访者认为大流行未影响药物处方实践,24.3%和16.5%分别减少生物制剂和糖皮质激素处方。
- 超过40%的受访者在大流行期间看到血管炎或冻疮患者数量增加。
- 约90%的受访者认为实践正在恢复至大流行前常规。
核心结论
- 研究结果表明大流行导致儿童风湿病学实践发生显著改变,包括处方抗风湿药物更谨慎、向远程医疗转变、常规诊疗延迟以及COVID-19相关炎症性疾病增加。
研究设计与样本
- 由儿童风湿病欧洲学会(PReS)新兴风湿病学家与研究者(EMERGE)组代表通过SurveyMonkey创建含22个问题的在线问卷,对70个国家的469名儿童风湿病学家进行国际横断面调查,并在SurveyMonkey上进行描述性分析。
主要发现
- 65.3%的受访者认为大流行未影响药物处方实践,24.3%和16.5%的受访者分别减少生物制剂和糖皮质激素处方。
- 超过40%的受访者在大流行期间看到血管炎或冻疮患者数量增加。
- 三分之一受访者表示在COVID-19大流行2.5年后临床实践未调整,其余受访者表示实施了各种改变,重点是纳入远程医疗。
- 远程医疗占三分之一参与者临床实践的≥10%。
- 35.5%的受访者同意由于大流行患者诊疗仍存在延迟,但大多数(约90%)认为实践正在恢复至大流行前常规。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The COVID-19 pandemic has affected patient care in general. We aimed to analyze the impact of the pandemic on pediatric rheumatology practice. METHODS: An online survey including 22 questions was created by the representatives of the Emerging RheumatoloGists and rEsearchers (EMERGE) group of the Pediatric Rheumatology European Society (PReS) on SurveyMonkey. The descriptive analysis of the responses was performed on SurveyMonkey. RESULTS: Overall, 469 pediatric rheumatologists (F/M: 2.9) from 70 countries completed the survey. The practice of drug prescription is not affected by the pandemic, according to 65.3 % of the respondents, while 24.3 % and 16.5 % are prescribing biologic drugs and corticosteroids less often, respectively. Over 40 % of the respondents have seen an increased number of patients with vasculitis or chilblains during the pandemic. One-third of the respondents stated no adjustments in their clinical practice after 2.5 years of COVID-19 pandemic. The rest indicated implementing various changes, with an emphasis on incorporating telemedicine. Telemedicine constitutes ≥10 % of the clinical practice for one-third of the participants. Nonetheless, 35.5 % agree that there are still delays in patient care due to the pandemic. However, most (∼90 %) think our practice is returning to the pre-pandemic routine. CONCLUSION: The findings of our study indicate a significant alteration in pediatric rheumatology practice due to the pandemic. This includes increased caution when prescribing anti-rheumatic drugs, a transition towards telemedicine utilization, delays in routine care, and a rise in COVID-19-related inflammatory conditions. It is imperative to address these aspects in order to improve patient care in pediatric rheumatology.
引用
- Batu ED, Demirkan FG, Sag E, et al. The impact of the COVID-19 pandemic on pediatric rheumatology practice: an international, cross-sectional survey study. Semin Arthritis Rheum. 2023. PMID: 37918050. doi:10.1016/j.semarthrit.2023.152289
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。